πŸ“£ VC round data is live. Check it out!

Cresco Labs Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cresco Labs and similar public comparables like SNDL, Canopy Growth, High Tide, Verano Holdings and more.

Cresco Labs Overview

About Cresco Labs

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.


Founded

1990

HQ

United States

Employees

2.9K

Financials (LTM)

Revenue: $655M
EBITDA: $152M

EV

$888M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cresco Labs Financials

Cresco Labs reported last 12-month revenue of $655M and EBITDA of $152M.

In the same LTM period, Cresco Labs generated $326M in gross profit, $152M in EBITDA, and had net loss of ($103M).

Revenue (LTM)


Cresco Labs P&L

In the most recent fiscal year, Cresco Labs reported revenue of β€” and net income of β€”.

See analyst estimates for Cresco Labs
LTM2025202620272028
Revenue$655M$656M
Gross Profit$326M$325M
Gross Margin50%50%
EBITDA$152M$157M
EBITDA Margin23%24%
EBIT Margin1%(4%)
Net Profit($103M)($140M)
Net Margin(16%)(21%)

Financial data powered by Morningstar, Inc.

Cresco Labs Stock Performance

Cresco Labs has current market cap of $334M, and enterprise value of $888M.

Market Cap Evolution


Cresco Labs' stock price is $0.93.

Cresco Labs share price decreased by 14.2% in the last 30 days, and increased by 52.6% in the last year.

See more trading valuation data for Cresco Labs
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$888M$334M0.0%-14.2%-6.6%52.6%β€”

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cresco Labs Valuation Multiples

Cresco Labs trades at 1.4x EV/Revenue multiple, and 5.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Cresco Labs

EV / Revenue (LTM)


Cresco Labs Financial Valuation Multiples

As of May 17, 2026, Cresco Labs has market cap of $334M and EV of $888M.

Cresco Labs has a P/E ratio of (3.3x).

LTM2025202620272028
EV/Revenue1.4x1.4x
EV/EBITDA5.9x5.6x
EV/EBIT125.2x(30.1x)
EV/Gross Profit2.7x2.7x
P/E(3.3x)(2.4x)
EV/FCF164.0x222.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cresco Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cresco Labs Margins & Growth Rates

See estimated margins and future growth rates for Cresco Labs

Cresco Labs Margins

20252026202720282029
Gross Margin50%50%
EBITDA Margin24%22%
EBIT Margin(4%)10%
Net Margin(21%)(6%)
FCF Margin1%1%

Cresco Labs Growth Rates

25/2626/2727/2828/29
Revenue Growth(0%)
Gross Profit Growth1%
EBITDA Growth(9%)
EBIT Growth(331%)
Net Profit Growth(71%)
FCF Growth95%

Data powered by FactSet, Inc. and Morningstar, Inc.

Cresco Labs Operational KPIs

Cresco Labs' Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cresco Labs' Rule of X is 21% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cresco Labs
LTMLast FY2025202620272028
Rule of 4024%21%β€”
Bessemer Rule of X26%21%β€”
G&A Expenses to Revenue34%β€”33%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cresco Labs Competitors

Cresco Labs competitors include SNDL, Canopy Growth, High Tide, Verano Holdings, TerrAscend, Aurora Cannabis, Organigram Global, Cannara Biotech, Vireo Growth and Ascend Wellness Holdings.

Most Cresco Labs public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
SNDL0.5x0.5x6.5x6.8x
Canopy Growth1.8x1.6x(20.6x)(31.4x)
High Tide0.7x0.6x10.5x8.7x
Verano Holdingsβ€”1.1xβ€”4.0x
TerrAscendβ€”1.6xβ€”6.2x
Aurora Cannabis0.8x0.7x5.1x4.7x
Organigram Global0.8x0.7x11.4x9.2x
Cannara Biotech1.7x1.6x6.4x6.0x

This data is available for Pro users. Sign up to see all Cresco Labs competitors and their valuation data.

Start Free Trial

Cresco Labs Funding History

Before going public, Cresco Labs raised $104M in total equity funding, across 2 rounds.


Cresco Labs Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Oct-18Series DBAM Elevate$100Mβ€”β€”
Sep-14Seedβ€”$4Mβ€”β€”

Cresco Labs M&A Activity

Cresco Labs has acquired 4 companies to date.

Last acquisition by Cresco Labs was on October 14th 2021. Cresco Labs acquired Laurel Harvest for $80M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Cresco Labs

Laurel Harvest
Cultivate
Bluma Wellness
Origin House
Description
Laurel Harvest Labs is a Hagerstown, Maryland-based medical marijuana dispensary emphasizing patient care. It dispenses cannabis flower, edibles, tinctures, and topicals from licensed growers, with services including consultations for conditions like chronic pain and anxiety under Maryland's Medical Cannabis Program.
Cultivate is a Leicester, Massachusetts-based cannabis dispensary founded in 2017 that sells medical and recreational products. It sources and produces high-quality flower, edibles, and concentrates, serving customers through its retail location and delivery services in Central Massachusetts.
Bluma Wellness is a vertically integrated medical cannabis company licensed in Canada for cultivation, processing, and distribution. It produces dried flower, oils, and edibles through facilities in Ontario, supplying dispensaries and pharmacies across provinces with THC and CBD products compliant with Health Canada regulations.
Origin House is an Ottawa-headquartered cannabis company operating in Canada and the United States with a focus on branded products. Established in 2015, it distributes over 130 cannabis brands including edibles, vapes, and flower to dispensaries across California. Origin House supplies the majority of licensed retailers in the world's largest regulated market. The firm expands internationally through licensing and production partnerships.
HQ CountryUnited StatesUnited StatesUnited StatesCanada
HQ City
Philadelphia, PA
β€”
Fort Lauderdale, FL
Ottawa
Deal Date14 Oct 202118 Mar 202114 Jan 20211 Apr 2019
Valuation$80M$160M$213M$428M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cresco Labs acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cresco Labs

When was Cresco Labs founded?Cresco Labs was founded in 1990.
Where is Cresco Labs headquartered?Cresco Labs is headquartered in United States.
How many employees does Cresco Labs have?As of today, Cresco Labs has over 2K employees.
Is Cresco Labs publicly listed?Yes, Cresco Labs is a public company listed on OTC Pink Sheets.
What is the stock symbol of Cresco Labs?Cresco Labs trades under CRLBF ticker.
Who are competitors of Cresco Labs?Cresco Labs main competitors include SNDL, Canopy Growth, High Tide, Verano Holdings, TerrAscend, Aurora Cannabis, Organigram Global, Cannara Biotech, Vireo Growth, Ascend Wellness Holdings.
What is the current market cap of Cresco Labs?Cresco Labs' current market cap is $334M.
What is the current revenue of Cresco Labs?Cresco Labs' last 12 months revenue is $655M.
What is the current revenue growth of Cresco Labs?Cresco Labs revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Cresco Labs?Current revenue multiple of Cresco Labs is 1.4x.
Is Cresco Labs profitable?Yes, Cresco Labs is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Cresco Labs?Cresco Labs' last 12 months EBITDA is $152M.
What is Cresco Labs' EBITDA margin?Cresco Labs' last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Cresco Labs?Current EBITDA multiple of Cresco Labs is 5.9x.
What is the current FCF of Cresco Labs?Cresco Labs' last 12 months FCF is $5M.
What is Cresco Labs' FCF margin?Cresco Labs' last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Cresco Labs?Current FCF multiple of Cresco Labs is 164.0x.
How many companies Cresco Labs has acquired to date?As of May 2026, Cresco Labs has acquired 4 companies.
What was the largest acquisition by Cresco Labs?$428M acquisition of Origin House on 1st April 2019 was the largest M&A Cresco Labs has done to date.
What companies Cresco Labs acquired?Cresco Labs acquired Origin House, Bluma Wellness, Cultivate, and Laurel Harvest.
In how many companies Cresco Labs has invested to date?Cresco Labs hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cresco Labs

Lists including Cresco Labs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial